Lymphodepleting chemotherapy with donor lymphocyte infusion post-allogeneic HCT for hematological malignancies is associated with severe, but therapy-responsive aGVHD

Donor lymphocyte infusion (DLI) is an option for relapsed hematologic malignancies or incomplete chimerism of non-malignant diseases following allogeneic hematopoietic cell transplantation (HCT). We analyzed the incidence of acute graft versus host disease (aGVHD) in patients treated with DLI. From...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Fiona, Warlick, Erica, Miller, Jeffrey S., MacMillan, Margaret, Verneris, Michael R., Cao, Qing, Weisdorf, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972636/
https://www.ncbi.nlm.nih.gov/pubmed/27064686
http://dx.doi.org/10.1038/bmt.2016.63

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972636/
https://www.ncbi.nlm.nih.gov/pubmed/27064686
http://dx.doi.org/10.1038/bmt.2016.63

Ejemplares similares